Jun 03, 2020
Avectas and UC Davis Collaborate on Cell Engineering Technology
May 29, 2020
Medicenna Presents Data on MDNA11, an IL-2 Superkine at ASCO 2020
May 14, 2020
Phio Presents Data on INTASYL as an Alternative to Genetic Modification to Improve Cell-based Immunotherapy at ASGCT 2020
May 12, 2020
Novel CAR NK-cell technology could lead to new treatments for lupus, other incurable diseases
May 06, 2020
Avectas and ONK Therapeutics to Develop Off-the-Shelf Cancer Therapy
Apr 27, 2020
Berkeley Lights Launches Two New Capabilities in the Opto Cell Therapy Development 1.0 Workflow to Accelerate the Creation Of Effective Cancer Immunotherapies
Apr 08, 2020
Avectas Announces Issuance of U.S. Patent for Cell Engineering Technology by the U.S. Patent and Trademark Office
Apr 02, 2020
Seattle's Infectious Disease Research Institute to coordinate the study of a novel COVID-19 treatment
Mar 25, 2020
Berkeley Lights Announces the Global Emerging Pathogen Antibody Discovery Consortium (GEPAD) to Attack COVID-19 and Other Viruses
Mar 25, 2020
Medicenna's IL-2 Superkine, MDNA19, Demonstrates Best-in-Class Features in a Non-Human Primate Study
Mar 24, 2020
Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies
Mar 17, 2020
GEMoaB Announces Publication of Pre-Clinical Proof-of-Concept Data on UniCAR-modified Off-the-shelf Natural Killer Cells in 'Nature Scientific Reports'
Mar 05, 2020
Berkeley Lights Launches T Cell Receptor Sequencing Kit to Increase Efficiency of T Cell Receptor Discovery
Jan 22, 2020
Celularity Announces FDA Clearance of Landmark IND for CYNK-001, an Allogeneic, Off-the-Shelf Cryopreserved NK Cell Therapy
Jan 10, 2020
Announcement of iPSC Derived Gene-modified NK Cell Development Targeting Solid Tumors
Dec 26, 2019
Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.
Dec 09, 2019
Nektar Therapeutics Announces Presentation of New Preclinical Data for its IL-15 Agonist, NKTR-255, at the American Society of Hematology (ASH) 2019 Annual Meeting
Nov 21, 2019
Phio Pharmaceuticals and Karolinska Institutet Expand Collaboration to Develop Self-Delivering RNAi Immunotherapies for Treating Solid Tumors
Sep 30, 2019
Arix Bioscience plc: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics
Sep 26, 2019
Nature Communications Publishes Studies on Medicenna's IL-2 Superkine Platform